Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-09 | 2023-04-06 | 186575 |
APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-04-14 | 2024-02-02 | 189647 |
APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-08-13 | 2023-10-15 | 201719 |
APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-01 | 2024-01-26 | 212362 |
APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-04-19 | 2024-06-14 | 225770 |
APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-06-06 | 2024-06-13 | 229761 |
APO-METHIMAZOLE | 5MG | TABLET | Actual shortage | 2017-08-14 | 2017-10-05 | 19320 |
APO-METHOTREXATE | 2.5MG | TABLET | Resolved | 2018-07-09 | 2021-07-23 | 54770 |
APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2017-03-11 | 2017-04-04 | 592 |
APO-METHYLPHENIDATE | 20MG | TABLET | Resolved | 2017-11-22 | 2018-01-25 | 30084 |
APO-METHYLPHENIDATE | 5MG | TABLET | Resolved | 2018-01-18 | 2018-03-13 | 36446 |
APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2018-03-05 | 2018-04-20 | 41858 |
APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2018-05-15 | 2018-09-12 | 49496 |
APO-METHYLPHENIDATE | 20MG | TABLET | Resolved | 2018-07-04 | 2018-10-11 | 54288 |
APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2019-01-09 | 2019-02-08 | 71673 |
APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2019-03-20 | 2019-07-06 | 79048 |
APO-METHYLPHENIDATE | 20MG | TABLET | Resolved | 2019-05-29 | 2019-07-12 | 85156 |
APO-METHYLPHENIDATE | 20MG | TABLET | Resolved | 2021-04-05 | 2021-05-17 | 136799 |
APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2021-10-22 | 2021-12-09 | 147818 |
APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2022-03-18 | 2022-04-18 | 156993 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
APO-VORICONAZOLE | 200MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60858 |
APO-VORICONAZOLE | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60861 |
APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40960 |